These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3724366)

  • 1. Tracer and maximal specific binding of tritiated spiperone or N-n-propylnorapomorphine to quantify dopamine receptors in rat brain regions in vivo.
    Van der Werf JF; Sebens JB; Korf J
    Life Sci; 1986 Jul; 39(2):155-60. PubMed ID: 3724366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Turnover of specific [3H]spiperone and [3H]N,n-propylnorapomorphine binding sites in rat striatum following phenoxybenzamine administration.
    Hall MD; Jenner P; Marsden CD
    Biochem Pharmacol; 1983 Oct; 32(19):2973-7. PubMed ID: 6626267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occupation of dopamine receptors by N-n-propylnorapomorphine or spiperone and acetylcholine levels in the rat striatum.
    Korf J; Sebens JB; Flentge F; van der Werf JF
    J Neurochem; 1985 Jan; 44(1):314-8. PubMed ID: 3964835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo labelling of rat brain dopamine D-2 receptors. Stereoselective blockade by the D-2 antagonist raclopride and its enantiomer of 3H-spiperone, 3H-N,N-propylnorapomorphine and 3H-raclopride binding in the rat brain.
    Köhler C; Karlsson-Boethius G
    J Neural Transm; 1988; 73(2):87-100. PubMed ID: 2974879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine receptor binding in bovine intermediate lobe pituitary membranes.
    Sibley DR; Creese I
    Endocrinology; 1980 Nov; 107(5):1405-9. PubMed ID: 7428676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional in vivo binding of [3H]N-propylnorapomorphine in the mouse brain. Evidence for labelling of central dopamine receptors.
    Köhler C; Fuxe K; Ross SB
    Eur J Pharmacol; 1981 Jul; 72(4):397-402. PubMed ID: 7274333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of in vivo spiperone binding in the rat striatum after lesions produced by kainate or decortication.
    Van der Werf JF; Van het Schip F; Sebens JB; Korf J
    Eur J Pharmacol; 1984 Jul; 102(3-4):387-99. PubMed ID: 6436037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions.
    List SJ; Seeman P
    Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2620-4. PubMed ID: 6941314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential anatomical location of [3H]-N,n-propylnorapomorphine and [3H]-spiperone binding sites in the striatum and substantia nigra of the rat.
    Hall MD; Jenner P; Kelly E; Marsden CD
    Br J Pharmacol; 1983 Jun; 79(2):599-610. PubMed ID: 6418246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional displacement by sulpiride of [3H]spiperone binding in vivo. Biochemical and behavioural evidence for a preferential action of limbic and nigral dopamine receptors.
    Köhler C; Ogren SO; Haglund L; Angeby T
    Neurosci Lett; 1979 Jun; 13(1):51-6. PubMed ID: 572522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3H]N-propylapomorphine and [3H]spiperone binding in brain indicate two states of the D2-dopamine receptor.
    Battaglia G; Titeler M
    Eur J Pharmacol; 1982 Jul; 81(3):493-8. PubMed ID: 6126376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo binding of N-n-propylnorapomorphine in the rat brain: regional localization, quantification in striatum and lack of correlation with dopamine metabolism.
    van der Werf JF; Sebens JB; Vaalburg W; Korf J
    Eur J Pharmacol; 1983 Feb; 87(2-3):259-70. PubMed ID: 6404643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine receptor binding sites in the rat superior colliculus.
    Chivers JK; Hall MD; Kelly E; Jenner P; Marsden CD
    J Pharm Pharmacol; 1984 Jul; 36(7):484-8. PubMed ID: 6146700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal conditions for [3H]apomorphine binding and anomalous equilibrium binding of [3H]apomorphine and [3H]spiperone to rat striatal membranes: involvement of surface phenomena versus multiple binding sites.
    Leysen JE; Gommeren W
    J Neurochem; 1981 Jan; 36(1):201-19. PubMed ID: 7463046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic dihydroergotoxine treatment affects the number of dopamine recognition sites in rat striatum.
    Battaini F; Govoni S; Rius RA; Spano PF; Trabucchi M
    Pharmacol Res Commun; 1984 Jun; 16(6):605-11. PubMed ID: 6463097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential labelling of dopamine receptors in rat brain in vivo: comparison of [3H]piribedil, [3H]S 3608 and [3H]N,n-propylnorapomorphine.
    Hall MD; Jenner P; Marsden CD
    Eur J Pharmacol; 1983 Jan; 87(1):85-94. PubMed ID: 6188621
    [No Abstract]   [Full Text] [Related]  

  • 17. Dopamine receptor sensitivity after chronic dopamine agonists. Striatal 3H-spiroperidol binding in mice after chronic administration of high doses of apomorphine, N-n-propylnorapomorphine and dextroamphetamine.
    Riffee WH; Wilcox RE; Vaughn DM; Smith RV
    Psychopharmacology (Berl); 1982; 77(2):146-9. PubMed ID: 6812131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple daily amphetamine administration decreases both [3H]agonist and [3H]antagonist dopamine receptor binding.
    Sibley DR; Weinberger S; Segal DS; Creese I
    Experientia; 1982 Oct; 38(10):1224-5. PubMed ID: 6890464
    [No Abstract]   [Full Text] [Related]  

  • 19. Regional blockade by neuroleptic drugs of in vivo 3H-spiperone binding in the rat brain. Relation to blockade of apomorphine induced hyperactivity and stereotypies.
    Köhler C; Haglund L; Ogren SO; Angeby T
    J Neural Transm; 1981; 52(3):163-73. PubMed ID: 7198139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of estrogens on the characteristics of [3H]spiroperidol and [3H]RU24213 binding in rat anterior pituitary gland and brain.
    Di Paolo T; Carmichael R; Labrie F; Raynaud JP
    Mol Cell Endocrinol; 1979 Nov; 16(2):99-112. PubMed ID: 116893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.